Endocardium defeat and heart valves at patients with systemic lupus erythematosus with antiphospholipid syndrome

Ignatenko G.A. ¹, Sinyachenko P.O.¹, Liventsova E.A.²

• ¹Донецкий национальный медицинский университет им. Максима Горького
• ²Донецкий медицинский университет им. Максима Горького

Summary. Antiphospholipid syndrome is only detected at patients with lupus endocarditis and heart defects (31%), and those, in turn, are diagnosed in 1,5 times more often in the presence of antiphospholipid antibody syndrome, which defines in systemic lupus erythematosus involving the aortic valve in pathological process, development of mitral and tricuspid insufficiency, lung and serous membranes, left atrium size, the degree of right ventricle, myocardium hypertrophy of left ventricular, left atrial and right ventricular, left ventricle ejection fraction, indicators of pulmonary vascular resistance and functional heart failure class.